SG Americas Securities
EWTX icon

SG Americas Securities’s Edgewise Therapeutics EWTX Stock Holding History

SG Americas Securities’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,804
Closed -$120K – 3452
2026
Q1 		$120K Sell
3,804
-84,919
-96% -$2.45M ﹤0.01% 2872
2025
Q4 		$2.2M Buy
88,723
+78,842
+798% +$1.58M ﹤0.01% 1463
2025
Q3 		$160K Buy
+9,881
New +$140K ﹤0.01% 2864
2025
Q2 		– Sell
-12,883
Closed -$283K – 3142
2025
Q1 		$283K Buy
+12,883
New +$338K ﹤0.01% 2256
2024
Q4 		– Sell
-29,629
Closed -$791K – 3276
2024
Q3 		$791K Sell
29,629
-34,544
-54% -$687K ﹤0.01% 1277
2024
Q2 		$1.16M Buy
64,173
+55,706
+658% +$972K 0.01% 1245
2024
Q1 		$154K Sell
8,467
-21,359
-72% -$339K ﹤0.01% 2180
2023
Q4 		$326K Buy
29,826
+11,128
+60% +$78.1K ﹤0.01% 1765
2023
Q3 		$107K Buy
+18,698
New +$127K ﹤0.01% 2750
2023
Q2 		– Sell
-15,080
Closed -$101K – 2549
2023
Q1 		$101K Buy
15,080
+1,447
+11% +$13.4K ﹤0.01% 2912
2022
Q4 		$122K Buy
13,633
+2,763
+25% +$25.9K ﹤0.01% 2579
2022
Q3 		$107K Sell
10,870
-464
-4% -$4.69K ﹤0.01% 2816
2022
Q2 		$90K Buy
+11,334
New +$85.7K ﹤0.01% 3156

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities's EWTX Position: Q2 2026 in Review

SG Americas Securities sold out of Edgewise Therapeutics (EWTX) in Q2 2026, closing a stake of 3,804 shares — an estimated $120K sold.

SG Americas Securities first reported a position in EWTX in Q2 2022 and held it in 13 quarters. The position peaked at $2.2M in Q4 2025. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • SG Americas Securities reported no remaining Edgewise Therapeutics position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 3,804 Edgewise Therapeutics shares in Q2 2026, an estimated $120K.
  • SG Americas Securities first reported a position in Edgewise Therapeutics in Q2 2022 and held it in 13 quarters.
  • SG Americas Securities's Edgewise Therapeutics position peaked at $2.2M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.